CMOs are looking to consolidate to increase their margins

CMO use on the up, low margins ahead

By Fiona BARRY

Contract manufacturing will rise over the next five years as drugmakers feel the pressure to reduce supply chain time, and choose to focus on in-house R&D rather than conduct their own manufacturing.

Parexel to lay off up to 125 transferred GSK employees


Parexel to lay off up to 125 transferred GSK employees

By Zachary Brennan

Beginning Sept. 30, Massachusetts-based CRO (contract research organization) Parexel will lay off as many as 125 of the 450 employees it brought on from GlaxoSmithKline (GSK) in North Carolina late last year, according to a North Carolina WARN report...

Some industry experts are doubting if consolidated companies can provide the same services as their former selves.

Dispatches from ChemOutsourcing

CMO consolidation: Do biopharma partners see any benefits?

By Zachary Brennan

As contract manufacturers continue to consolidate, some in the industry are questioning whether the resulting companies have the ability to offer the same services as the former individual companies. 

The acquisition will grow Chiltern's presence in the US.

Chiltern taps oncology expertise with Ockham acquisition

By Zachary Brennan

UK-based CRO Chiltern has agreed to acquire Ockham, a North Carolina-based full-service CRO, and the combined company will now compete with mid-sized CROs. Financial terms of the acquisition were not announced.

Follow us


View more